The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology
- 1Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
- 2State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China
- 3RNA Therapeutics Institute, Chan Medical School, University of Massachusetts Worcester, Worcester, MA, United States
- 4Krembil Research Institute, University of Health Network, Toronto, ON, Canada
- 5Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
- 6Department of Microbiology, Quaid-I- Azam University, Islamabad, Pakistan
- 7Department of Biotechnology, Baluchistan University of Information Technology, Engineering and Management Sciences (BUITEMS), Quetta, Pakistan
A Corrigendum on
The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology
by Qudus MS, Cui X, Tian M, Afaq U, Sajid M, Qureshi S, Liu S, Ma J, Wang G, Faraz M, Sadia H, Wu K and Zhu C (2023) Front. Cell. Infect. Microbiol. 13:1196699. doi: 10.3389/fcimb.2023.1196699
In the published article, there was an error regarding the affiliations for authors Siyu Liu, Kailang Wu and Chenglian Zhu. Author Siyu Liu should instead of having affiliation 1, have “State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China”. Author Kailang Wu should instead of affiliation 1, have “State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China”. Author Chengliang Zhu should, instead of affiliation 2 have “Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China”. The corrected affiliations appear above.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: monkeypox, MPOX infection, MPOX vaccination, MPOX immunity, MPOX diagnosis
Citation: Qudus MS, Cui X, Tian M, Afaq U, Sajid M, Qureshi S, Liu S, Ma J, Wang G, Faraz M, Sadia H, Wu K and Zhu C (2023) Corrigendum: The prospective outcome of the Monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology. Front. Cell. Infect. Microbiol. 13:1284014. doi: 10.3389/fcimb.2023.1284014
Received: 27 August 2023; Accepted: 07 September 2023;
Published: 18 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Qudus, Cui, Tian, Afaq, Sajid, Qureshi, Liu, Ma, Wang, Faraz, Sadia, Wu and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chengliang Zhu, emh1Y2hlbmdsaWFuZ0B3aHUuZWR1LmNu; Kailang Wu, d3VrYWlsYW5nQHdodS5lZHUuY24=
†These authors have contributed equally to this work